Año
Autores / Publicación
Luna Nophal, A., Díaz Castillo, J. F., Izquierdo Sanchez, V., Velazquez Fernandez, J., Orozco Morales, M., Lara Mejia, L., Bernáldez Sarabia, J., Sánchez Campos, L. N., Arrieta, O., Diaz Chavez, J., Castañeda Sanchez, J. I., Licea Navarro, A. F., & Muñiz Hernández, S. (2025). Preclinical Efficacy and Proteomic Prediction of Molecular Targets for s-cal14.1b and s-cal14.2b Conotoxins with Antitumor Capacity in Xenografts of Malignant Pleural Mesothelioma. Marine Drugs, 23(1), 32. doi: 10.3390/md23010032. (ID: 30624)
Cabanillas Bernal, O., Valdovinos Navarro, B. J., Cervantes Luevano, K. E., Sánchez Campos, L. N., & Licea Navarro, A. F. (2023). Unleashing the power of shark variable single domains (VNARs): broadly neutralizing tools for combating SARS-CoV-2. Frontiers in Immunology, 14(1257042), 1-11. doi: 10.3389/fimmu.2023.1257042. (ID: 29940)
Sánchez Campos, L. N., Bernáldez Sarabia, J., & Licea Navarro, A. F. (2022). Conotoxin Patenting Trends in Academia and Industry. Marine Drugs, 20(531), 22. doi: 10.3390/md20080531. (ID: 27869)
Ventura López, C., Cervantes Luevano , K. E., Aguirre Sanchez, J., Flores Caballero, J., Álvarez Delgado, C., Bernáldez Sarabia, J., Sánchez Campos, L. N., Lugo Sanchez, L., Rodriguez Vazquez, I., Sander Padilla, J., Romero Antonio, Y., Arguedas Nuñez, M., Gonzalez Canudas, J., & Licea Navarro, A. F. (2022). Treatment with metformin glycinate reduces SARS-CoV-2 viral load: An in vitro model and randomized, double-blind, Phase IIb clinical trial. Biomedicine & Pharmacotherapy, 152, 9. doi: 10.1016/j.biopha.2022.113223. (ID: 27863)
Lugo Fabres, P. H., Otero Sastre, L., Bernáldez Sarabia, J., Camacho Villegas, T. A., Sánchez Campos, L. N., Serrano Bello, J., Medina, L., Muñiz Hernández, S., de la Cruz, L., Arenas, I., Barajas Martinez, A., García, D. E., Nuñez Garcia, L., Gonzalez Canudas, J., & Licea Navarro, A. F. (2021). Potential Therapeutic Applications of Synthetic Conotoxin s-cal14.2b, Derived from Californiconus californicus, for Treating Type 2 Diabetes. Biomedicines, 9(8), 936. doi: 10.3390/biomedicines9080936. (ID: 26995)
Millán Gómez, D. V., Dueñas Espinoza, S., Muñoz, P. L. A., Camacho Villegas, T. A., Elosua, C., Cabanillas Bernal, O., Escalante, T., Almudena, P., Abia, D., Drescher, F. C. L., Fournier, P. G. J., Ramos Ibarra, M. A., Mares, R. E., Paniagua Solís, J. F., Mata González, M. T., Gonzalez Canudas, J., Hoffman, R., Licea Navarro, A. F., & Sánchez Campos, L. N. (2018). In silico-designed mutations increase variable new-antigen receptor single-domain antibodies for VEGF165 neutralization. Oncotarget, 9(46), 28016-28029. doi: 10.18632/oncotarget.25549. (ID: 23951)
de León Nava, M. A., Romero Núñez, E., Luna Nophal, A., Bernáldez Sarabia, J., Sánchez Campos, L. N., Licea Navarro, A. F., Morales Montor, J., & Muñiz Hernández, S. (2016). In Vitro Effect of the Synthetic cal14.1a Conotoxin, Derived from Conus californicus, on the Human Parasite Toxoplasma gondii. Marine Drugs, 14(4). doi: 10.3390/md14040066. (ID: 20859)
Oroz Parra, I., Navarro Armenta, M. F., Cervantes Luévano, K., Álvarez Delgado, C., Salvesen, G., Sánchez Campos, L. N., & Licea Navarro, A. F. (2016). Apoptosis activation in human lung cancer cell lines by a novel synthetic peptide derived from Conus californicus venom. Toxins, (82), 2. doi: 10.3390/toxins8020038. (ID: 19958)